This contract will expand the treatment volume to more than 100,000m³ per day (m³/d). PolyCera will supply the complete membrane solution for this project, including elements, pressure vessels and ...

Protagonist Therapeutics and its partner Johnson & Johnson have reported four phase III wins for their IL-23 receptor targeted peptide icotrokinra in plaque psoriasis, as well as a phase II ...

However, the localization accuracy of existing branching IDFOVS will deteriorate if affected by dual fiber phase shift difference (DFPSD). This article introduces an improved branching IDFOVS with ...

The best and worst assignments are identified using the absolute sum of phase differences with reference to a straight waveguide, defined as the difference between the transmission phase of a ...